NCT03830723

Personalized Insemination Treatment Study

Effect of Personalized Dosages of Rekovelle on the Number of Mature Follicles Reached in Intra-uterine Insemination

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 110 (actual)
• Sponsor: Clinique Ovo · Industry
• Sex: Female
• Age: 18 Years – 42 Years
• Healthy volunteers: Accepted

Summary

This study is intended for women undergoing their first cycle of 3 intrauterine inseminations. All 3 inseminations will be personalized by using algorithms to determine the dose of study medication.

Detailed description

Study medication dosage for the first insemination cycle will be based on the woman's age as well as her Anti-Mullerian Hormone (AMH) levels. Study medication dosage for the second and third insemination will depend on ovarian response (number of follicles) during previous insemination cycle and woman's age

Conditions

• Infertility
• Intrauterine Insemination
• Reproduction

Interventions

Type	Name	Description
DRUG	Follitropin delta	Study medication doses during all 3 insemination will be personalized using a suggested algorithm

Timeline

• Start date: 2020-01-09
• Primary completion: 2021-01-20
• Completion: 2021-09-27
• First posted: 2019-02-05
• Last updated: 2022-09-13

Locations

1 site across 1 country: Canada